News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Start News Corporate Action Prospectus

Press releases

Regulatory

April 28, 2022

Egetis Therapeutics publishes prospectus relating to the Rights Issue

Regulatory

November 12, 2020

PledPharma publishes a supplement to the prospectus

Regulatory

November 5, 2020

PledPharma publishes prospectus and updated financial information in connection with fully guaranteed rights issue and the admission to trading of shares

Regulatory

October 29, 2019

PledPharma publishes prospectus in connection with the list change to Nasdaq Stockholm’s main market

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com

Press releases

Calendar and upcoming reports

Subscribe

Contact us